A case of lichen ruber planus in a patient with familial multiple sclerosis

Journal of International Medical Research

Volumn 38, Issue 5, 2010, Pages 1856-1860

  Sepcic J ^a   Ristic R ^a   Perkovic O ^a   Brinar, V ^b   LipozenciC L ^b   Crnic Martinovic M ^a   Starcevic Cizmarevic N ^a   Janko Labinac, D ^c   Kapovic M ^a   Peterlin, B ^d  

^a UNIVERSITY OF RIJEKA   (Croatia)

^b UNIVERSITY OF ZAGREB   (Croatia)

^c GENERAL HOSPITAL PULA   (Croatia)

^d UNIVERSITY OF LJUBLJANA   (Slovenia)

Author keywords

Autoimmune skin disorders; Case study; Familial multiple sclerosis; Lichen ruber planus

Indexed keywords

BETA GLOBULIN; BETAMETHASONE; CETIRIZINE; HLA DR ANTIGEN; HLA DRB5 ANTIGEN; IMMUNOGLOBULIN G; LORATADINE; METHYLPREDNISOLONE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CASE REPORT; DETERIORATION; DISEASE ASSOCIATION; DRUG EFFICACY; EVOKED VISUAL RESPONSE; FATIGUE; FEMALE; HUMAN; HUMAN TISSUE; INFLAMMATORY INFILTRATE; LICHEN PLANUS; LYMPHOCYTOSIS; MONOCULAR VISION; MULTIPLE SCLEROSIS; NEUROLOGIC EXAMINATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PARESTHESIA; PROTEIN ELECTROPHORESIS; PYRAMIDAL SIGN; RELAPSE; SKIN BIOPSY;

EID: 78449293441     PISSN: 03000605     EISSN: None     Source Type: Journal    
DOI: 10.1177/147323001003800533     Document Type: Article

References (24)

1. Lassmann H, Wekerle H: The pathology of multiple sclerosis. In: McAlpine's Multiple Sclerosis (Compston A, ed). Edinburgh: Churchill Livingstone, 2006; pp 598-599.
2. Marshman G: Lichen planus. Australas J Dermatol 1998; 39: 1-13.
3. Venencie PY, Rosers RS, Schroeter AL: Bullous pemphigoid and malignancy: relationship to indirect immunofluorescent findings. Acta Derm Venereol 1984; 64: 316-319.
4. Simjee S, Konqui A, Razzaque-Ahmed A: Multiple sclerosis and bullous pemphigoid. Dermatologica 1985; 170: 86-89.
5. Anonide A, Rebora A: What lichen planus patients die of. Int J Dermatol 1989; 28: 524-526.
6. McGrath EJ, Davies MG: Lichen sclerosus arising from a chronic wound and coexistent with multiple sclerosis. J Eur Acad Dermatol Venereol 2005; 19: 139-141.
7. Poser CM, Paty DW, Scheinberg L, et al: New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 1983; 13: 227-231.
8. Compston A, Confavreux C: The environmental factor in multiple sclerosis. In: McAlpine's Multiple Sclerosis (Compston A, ed). Edinburgh: Churchill Livingstone, 2006; pp 105-111.
9. Compston A, Wekerle H, McDonald IW: The origin of multiple sclerosis: a synthesis. In: McAlpine's Multiple Sclerosis (Compston A, ed). Edinburgh: Churchill Livingstone, 2006; pp 273-284.
10. Eisen D: The clinical features, malignant potential, and systemic associations of oral lichen planus: a study of 723 patients. J Am Acad Dermatol 2002; 46: 207-214.
11. McDonald I, Compston A: Associated diseases. In: McAlpine's Multiple Sclerosis (Compston A, ed). Edinburgh: Churchill Livingstone, 2006; pp 341-343.
12. Wekerle H, Lassmann H: The immunology of inflammatory demyelinating disease. In: McAlpine's Multiple Sclerosis (Compston A, ed). Edinburgh: Churchill Livingstone, 2006; pp 491-547.
13. Keate RF, Williams JW, Connolly SM: Lichen planus esophagitis: report of three patients treated with oral tacrolimus or intraesophageal corticosteroid injections or both. Dis Esophagus 2003; 16: 47-53.
14. Fivenson DP, Mathes B: Treatment of generalized lichen planus with alefacept. Arch Dermatol 2006; 142: 151-152.
15. Noseworthy J, Confavreux C, Compston A: The treatment of multiple sclerosis. In: McAlpine's Multiple Sclerosis (Compston A, ed). Edinburgh: Churchill Livingstone, 2006; pp 683-699.
16. Ismail SB, Kumar SK, Zain RB: Oral lichen planus and lichenoid reactions: etiopathogenesis, diagnosis, management and malignant transformation. J Oral Sci 2007; 49: 89-106.
17. Davenport CB: Multiple sclerosis from the standpoint of geographic distribution and race. Arch Neurol Psychiatry 1922; 8: 51-58.
18. Ghodsi SZ, Daneshpazhooh M, Shahi M, et al: Lichen planus and hepatitis C: a case-control study. BMC Dermatol 2004; 4: 6.
19. Ramagopalan SV, Dyment DA, Valdar W, et al: Autoimmune disease in families with multiple sclerosis: a population-based study. Lancet Neurol 2007; 6: 604-610.
20. Barcellos LF, Kamdar BB, Ramsay PP, et al: Clustering of autoimmune diseases in families with a high-risk for multiple sclerosis: a descriptive study. Lancet Neurol 2006; 5: 924-931.
21. Nielsen NM, Frisch M, Rostgaard K, et al: Autoimmune diseases in patients with multiple sclerosis and their first-degree relatives: a nationwide cohort study in Denmark. Mult Scler 2008; 14: 823-829.
22. Henderson RD, Bain CJ, Pender MP: The occurrence of autoimmune diseases in patients with multiple sclerosis and their families. J Clin Neurosci 2000; 7: 434-437.
23. Meiner Z, Zlotogorski A, Brautbar C: Pemphigus associated with multiple sclerosis. Clin Exp Dermatol 1992; 17: 217.
24. Gorodkin R, Leahy B, Neary D, et al: Coexistence of systemic sclerosis and multiple sclerosis. J Neurol 2004; 251: 1524-1525.